Communications Biology (May 2022)
IL-25 blockade augments antiviral immunity during respiratory virus infection
Abstract
IL-25 and its receptor are expressed in airway epithelial cells of healthy individuals and patients with asthma and antibody-mediated blockade of IL-25 enhances antiviral immunity and blocks virus-exacerbated asthma responses.